Microbiota: Analysis and Explanation of the Human Microbial Groups

Lecturer: Dr Francesco Di Pierro

40.00

In this lecture, Dr Di Pierro, thanks to his extensive experience and research work, will illustrate microbiota and its role in health manifestation. The webinar aims to address the genesis of the structure and ecology of the faecal microbiota, considering the possible correlations with intestinal and non-intestinal diseases.

Description

 Microbiota: Analysis and Explanation of the Human Microbial Groups

14th September, from 5 p.m. to 7 p.m. (Italian time zone)

 

Lecturer: Francesco Di Pierro

This webinar will be held in Italian.

 

WEBINAR PRESENTATION

We frequently hear about the microbiota and microbiome as an essential feature in human beings’ health and metabolic functioning.

In this lecture, Dr Di Pierro, thanks to his extensive experience and research work, will illustrate microbiota and its role in health manifestation.

The webinar aims to address the genesis of the structure and ecology of the faecal microbiota, considering the possible correlations with intestinal and non-intestinal diseases.

Also, we will discuss the microbiota in the vaginal and oral areas. Finally, we will describe the pulmonary microbiota, a topic that became highly relevant due to the COVID-19 pandemic.

Understanding the microbiota and how a process of dysbiosis can generate symptoms and disorders that an osteopath can pick up during the evaluation, such as musculoskeletal pain, gives us an additional tool to support, help, and restore patients’ health.

During the webinar, we will cover the following topics:

– the genesis of the structure and ecology of the faecal microbial groups,

– possible links with the intestinal and non-intestinal diseases,

– the vaginal, oral, and, given the great interest during the COVID-19 pandemic, lung microbiota.

 

LECTURER

Francesco Di Pierro is a biologist, pharmacologist and author of numerous scientific articles; also, he holds a PhD in immunology. He is an adjunct lecturer at several Italian universities (Camerino, Milan, Pavia) on nutraceutical, phytotherapeutic and biopharmaceutical subjects. He is a member of the scientific editorial board of several international journals (Journal of Alternative and Integrative Medicine; Core Evidence; International Journal of Physiology, Pathophysiology and Pharmacology; International Journal of Case Reports and Images; American Journal of Digestive Disease) and, since 2015, he is editor-in-chief for Nutrafoods (Springer/CEC).

He is the author of “Argomenti di fitoterapia biofarmaceutica” (2014, CEC Editore), “Topics on Biopharmaceutical Phytotherapy” (2016, CEC Editore), “Argomenti di terapia batterica” (2015, CEC Editore) and co-author of “Nutrizione e dietologia. Aspetti clinici dell’alimentazione” (2015, Zanichelli Editore) and “Trattato di nutraceutica clinica” (2017, Scripta Manent Editore). He was awarded for his research work by the French Society of Cosmetology (2000) and the Spanish Royal Society of Chemistry (2001). He carried out his research career first as a postgraduate fellow at the Institute of Microbiology in Turin (1990-1993), then as laboratory chief at Centro Ricerche Italfarmaco (1993-1996). Afterwards, he became a senior scientist at Direzione Scientifica Indena (1996-2002), scientific director at SIIT Farmaceutici (2002-2007) and finally scientific and research director at Velleja Research (from 2008 to date). He is currently a nutritional consultant and scientific director of MyMicrobiota. At the Operative Unit of Gastroenterology in Brescia, he has launched, together with Fondazione Poliambulanza, a course dedicated to studying the intestinal microbiota.

Additional information

LEZIONI

1 lezione, tutte le lezioni